Michelle Lynn Halfman, MS CCC SLP | |
845 S Main St, Fond Du Lac, WI 54935-6174 | |
(920) 322-0447 | |
Not Available |
Full Name | Michelle Lynn Halfman |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 845 S Main St, Fond Du Lac, Wisconsin |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164634622 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 1540-154 (Wisconsin) | Primary |
Provider Name | Aspirus Medical Group Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1669595294 PECOS PAC ID: 1052223625 Enrollment ID: O20031103000267 |
News Archive
MedAptus®, the market leader in charge capture technologies, announced today that it has been awarded U.S. patent number 7,685,002 entitled "Method and System for Processing Medical Billing Records." The patent pertains to MedAptus' automated process for completely and accurately capturing both professional and facility charges in outpatient settings.
Norma Crosby remembers when she relied on blind faith to cast her vote.
Poor dental health may be linked with increased risk for diabetes, a new study suggests. The results will be presented in a poster Monday, March 19, at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Clonidine Hydrochloride Injection in two dosage strengths.
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today that its 75-patient Phase II clinical study with CF101 to treat patients with moderate to severe Psoriasis has successfully met its primary objectives.
› Verified 5 days ago
Provider Name | Aspirus Wausau Hospital Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1922321140 PECOS PAC ID: 6406757442 Enrollment ID: O20040114000297 |
News Archive
MedAptus®, the market leader in charge capture technologies, announced today that it has been awarded U.S. patent number 7,685,002 entitled "Method and System for Processing Medical Billing Records." The patent pertains to MedAptus' automated process for completely and accurately capturing both professional and facility charges in outpatient settings.
Norma Crosby remembers when she relied on blind faith to cast her vote.
Poor dental health may be linked with increased risk for diabetes, a new study suggests. The results will be presented in a poster Monday, March 19, at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Clonidine Hydrochloride Injection in two dosage strengths.
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today that its 75-patient Phase II clinical study with CF101 to treat patients with moderate to severe Psoriasis has successfully met its primary objectives.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Michelle Lynn Halfman, MS CCC SLP 845 S Main St, Fond Du Lac, WI 54935-6174 Ph: (920) 322-0447 | Michelle Lynn Halfman, MS CCC SLP 845 S Main St, Fond Du Lac, WI 54935-6174 Ph: (920) 322-0447 |
News Archive
MedAptus®, the market leader in charge capture technologies, announced today that it has been awarded U.S. patent number 7,685,002 entitled "Method and System for Processing Medical Billing Records." The patent pertains to MedAptus' automated process for completely and accurately capturing both professional and facility charges in outpatient settings.
Norma Crosby remembers when she relied on blind faith to cast her vote.
Poor dental health may be linked with increased risk for diabetes, a new study suggests. The results will be presented in a poster Monday, March 19, at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Clonidine Hydrochloride Injection in two dosage strengths.
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today that its 75-patient Phase II clinical study with CF101 to treat patients with moderate to severe Psoriasis has successfully met its primary objectives.
› Verified 5 days ago
Kerry A Winget, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-923-5378 | |
Kendalyn Susan Voss, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 420 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 | |
Linda Vande Zande, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 244 N Macy St, Fond Du Lac, WI 54935 Phone: 920-926-0050 | |
Mrs. Lisa Marie Coulter, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 E Arndt St, Fond Du Lac, WI 54935 Phone: 920-923-7054 Fax: 920-923-7058 | |
Angeleen Dodge, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 N Park Ave, Fond Du Lac, WI 54935 Phone: 920-929-8858 Fax: 920-923-3038 | |
Monica Garvey Krueger, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 E Arndt St, Fond Du Lac, WI 54935 Phone: 920-923-7040 |